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Abstract
Anterior Cruciate Ligament (ACL) injuries are an upsetting setback for
many athletes that require a long and costly recovery process. The
injury rates are four times greater in women than men. Preventative
measures that help to prevent ACL injuries are limited to stretching
and strengthening. Therefore, this review aims to investigate if oral
contraceptive [I] usage provides a possible new avenue for prevention
of ACL injury [O] in young female athletes (ages 18-30) [P] compared
to those that do not take oral contraceptives [C].

1. Arendt A., Bershadsky B. and Agel J. Periodicity of noncontact anterior cruciate ligament injuries during the menstrual cycle. The Journ of
Gend Specif Med, 2002;5(2), pp.19-26.
• Retrospective cohort study of 83 participants aimed to compare the number of total ACL tears in females taking OCP vs not taking OCP
over the span of 3 years
2. Gray A, Gugala Z, Baillageon J. Effects of Oral Contraceptive Use on Anterior Cruciate Ligament Injury Epidemiology. Medicine & Science
in Sports & Exercise. 2016;48(4):648-654. doi:10.1249/mss.0000000000000806.
• Case control study of 347,118 participants designed to investigate what percent of OCP users underwent ACL reconstruction compared to
non-users.
3. Hicks-Little C, Thatcher J, Hauth M, Goldfuss A, Cordova M. Menstrual cycle stage and oral contraceptive effects on anterior tibial
displacement in collegiate female athletes. J Sports Med Phys Fitness. 2007;47(2):255-260.
• Case control study of 53 participants aimed to establish differences in anterior tibial translation in female athletes at varying stages of their
menstrual cycles
4. Konopka J, DeBaun M, Chang W, Dragoo J. The Intracellular Effect of Relaxin on Female Anterior Cruciate Ligament Cells. Am J Sports
Med. 2016;44(9):2384-2392. doi:10.1177/0363546516646374
• Laboratory experiment of 14 donors designed to investigate serum relaxin levels in estrogen-treated tissue samples compared to nonestrogen treated
5. Lefevre N, Bohu Y, Klouche S, Lecocq J, Herman S. Anterior cruciate ligament tear during the menstrual cycle in female recreational skiers.
Orthopaedics & Traumatology: Surgery & Research. 2013;99(5):571-575. doi:10.1016/j.otsr.2013.02.005.
• Retrospective cohort study of 172 participants designed to find the distribution of ACL tears according to stage in menstrual cycle and oral
contraceptive usage vs non-usage.

Introduction
Anterior Cruciate Ligament (ACL) injury

Statistics
• ACL injury rates 4x > in F:M
• Roughly 200,000 tears per year in US as of 2017
• Reconstructive treatments= ~ $7.6 billion per year
• Rehabilitative treatments= ~ $17.7 billion per year

Methods

Study

Population
Demographics

Control

Exclusion Criteria

1

83 Females

Non OCP users

None

OCP users

% of ACL injuries

2

347,118 Females

Healthy age-matched
female ACL (3:1)

History of hormonal disruptive
condition, PCOS, hysterectomy,
Turner syndrome,
follicular/ovarian cyst, atrophy of
ovary/fallopian tube,
benign/malignant neoplasm of
ovary, oophorectomy, pregnant
state/ectopic in last 12 mo.

OCP users

% undergoing ACL
repair

•

Search Terms:
•
•
•

‘

“ACL” AND “oral contraceptives”
“menstrual cycle” AND “ACL injury” AND
“oral contraceptives”
“ACL injury” OR “joint laxity” AND “oral
contraceptive”.

•

Inclusion Criteria:
•
•
•
•
•
Exclusion Criteria:
•
•
•
•

3

4

53 Females

7 Males, 7 Females

Non OCP users

Strengths
• Statistically significantà All utilized 2 methods of data analyses and all p value < 0.05
• 8/8 used inclusion/exclusion criteria, which resulted in decreased amount of confounding variables
Limitations
• Large differences in sample sizes
• Low external validity à none measured duration of OCP treatment nor described what type/strength of OCP
• None measured how long participants had been on OCP treatment
• Lack of long-term follow up
Future Research
• Inclusion/exclusion criteria applied in order to account for type/strength of OCP and duration
• Obtain information such as level of compliance and what day of the menstrual cycle the tears were on
• Obtain follow up and compare recovery rates in OCP users vs non-users
• More laboratory experiments on cadaver ACLs testing various forms of estrogen, progesterone, and measuring serum relaxin-2.

Systematic reviews or meta-analyses
Male participants
Injuries other than ACL
Ages other than 18-30 y/o

5

172 Females

KT-1000
measurements of
anterior tibia
translation

None

Treated
with
concentrati
ons of
relaxin-2 or
TGFβ1 or
17βestradiol

MMP1, MMP3,
MMP13, type I
collagen, type III
collagen, mRNA

Non OCP users

None

OCP users

% of ACL injuries

(mean age 34 +/- 8.7
years)

6

172 Females

None

None

OCP users

KT-1000
measurements of
anterior tibia
translation

7

106 Females

Non OCP users

Serum relaxin-2 < 6.0 pg/mL

OCP users

Hormone levels from
blood samples
(serum-relaxin 2)

Healthy age-matched
female ACL (2:1)

For the controls: prior ACL
injury

OCP users

% ACL injuries

13 amenorrhea, 77 regular
menstruation, 16 prior OC
usage

8

13,355 Females
Median age= 24 y/o

The study reveals a significant difference in OCP-users vs non-users in terms of joint laxity and % of overall ACL tears.
Although there are limitations to some of this research, it provides a great blueprint for future studies and provokes some
great ideas for clinical practice.
The determination of utilizing OCP in the future for ACL prevention should be made on a case by case basis. Potential
contraindications such as personal or family history of breast cancer or clotting disorders must be taken into consideration.

Until more research is performed and these questions are answered, it remains unclear if OCPs are a safe and effective
preventative measure for ACL injury.. There is not yet enough evidence to safely utilize this in practice yet.

Prior ACL injury

Race: Hispanic (1), White (10),
American Indian (1), Asian (2)

Conclusion

Many questions and technical issues regarding how to best utilize OCPs must first be determined prior to bringing this into
clinical practice- specifically, the duration, form, and strength of the OCP usage. This should be the aim of future research.

For control: no previous history OCP users
of knee injury or anomalies and
normal 28-30 day menstrual
cycle

F Ages: 19, 40, 20, 13, 46, 43,
20
M ages: 36, 23, 26, 51, 20, 19,
26

Published in peer-reviewed journal
Published within last 10 years
Human participants as subjects
Female participants
Age range 18-30 y/o

Tx
Outcome Measure
Compared

Emergency contraception,
implantable devices, hormonal
IUDs, injectable/patch
contraceptives

Literature Search
•

2/2 studies that measured anterior tibial translation in OCP users vs non-users found significantly less translation in OCPusers.

6. Martineau P, Al-Jassir F, Lenczner E, Burman M. Effect of the Oral Contraceptive Pill on Ligamentous Laxity. Clinical Journal of Sport
Medicine. 2004;14(5):281-286. doi:10.1097/00042752-200409000-00006.
• Post-test control study of 172 participants designed to identify if there was a difference in joint laxity between OCP and non-OCP users by
measuring KT-1000 measurements of anterior tibia translation

8. Rahr-Wagner L, Thillemann T, Mehnert F, Pedersen A, Lind M. Is the Use of Oral Contraceptives Associated With Operatively Treated
Anterior Cruciate Ligament Injury?. Am J Sports Med. 2014;42(12):2897-2905. doi:10.1177/0363546514557240.
• Case control study of 4,497 participants designed evaluate percentage of OCP-users vs non-users in ACL tears, and furthermore, which
percentage underwent reconstruction.

Current Prevention
• Stretching, strengthening, and mobility exercises aimed to release tension and
tightness on the joint and strengthen muscles around the knee joint

Performed in October 2018 using
• PubMed
• Google Scholar
• SCOPUS
• ClinicalKey

3/4 studies that analyzed % of ACL tear in OCP users vs non-users found less risk in OCP users; the other found no
significant difference.

7. Nose-Ogura S, Yoshino O, Yamada-Nomoto K et al. Oral contraceptive therapy reduces serum relaxin-2 in elite female athletes. Journal of
Obstetrics and Gynecology Research. 2016;43(3):530-535. doi:10.1111/jog.13226.
• Case control study of 106 participants designed evaluate serum-relaxin- 2 levels in OCP users vs non-users.

Physiology
• Estrogen has effect on collagen, altering its tensile properties of ligaments in ACL
fibroblast
• Neuromuscular performance varies during the menstrual cycle
• Elevated serum relaxin-2 levels correlate with increased ACL injuries.

•

Discussion

Key: OCP= Oral Contraception, ACL= Anterior Cruciate Ligament, KT-1000= Knee Laxity
Testing Device, MMP1= collagenase-1, MMP3= stromelysin-1, MMP13= collagenase-3

Overall, the meta-analysis reveals positive outcomes in utilizing OCPs as a preventative measure in ACL injury, but the
evidence is insufficient to begin use in clinical practice.
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